These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6388275)

  • 21. Coeliac disease: ecology, life history and management.
    McNicholl B
    Hum Nutr Appl Nutr; 1986; 40 Suppl 1():55-60. PubMed ID: 3528073
    [No Abstract]   [Full Text] [Related]  

  • 22. HLA antigens and toxic reactions to sodium aurothiomalate in patients with rheumatoid arthritis.
    Bensen WG; Moore N; Tugwell P; D'Souza M; Singal DP
    J Rheumatol; 1984 Jun; 11(3):358-61. PubMed ID: 6234391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Major histocompatibility complex.
    Goust JM
    Immunol Ser; 1993; 58():29-48. PubMed ID: 8424978
    [No Abstract]   [Full Text] [Related]  

  • 24. Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA-DR3.
    Price P; Santoso L; Mastaglia F; Garlepp M; Kok CC; Allcock R; Laing N
    Tissue Antigens; 2004 Nov; 64(5):575-80. PubMed ID: 15496200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the major histocompatibility complex class I antigens in tumor growth and metastasis.
    Tanaka K; Yoshioka T; Bieberich C; Jay G
    Annu Rev Immunol; 1988; 6():359-80. PubMed ID: 3289570
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetic regulation of the immune response in man.
    Matej H
    Acta Anthropogenet; 1985; 9(1-3):20-30. PubMed ID: 3939669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of HLA antigens in the manifestation and course of Graves' disease.
    Stenszky V; Kozma L; Balazś C; Bear JC; Farid NR
    Mol Biol Med; 1986 Feb; 3(1):53-62. PubMed ID: 3485758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter.
    Schleusener H; Schernthaner G; Mayr WR; Kotulla P; Bogner U; Finke R; Meinhold H; Koppenhagen K; Wenzel KW
    J Clin Endocrinol Metab; 1983 Apr; 56(4):781-5. PubMed ID: 6131902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA and bone marrow transplantation.
    Bach FH
    Prog Clin Biol Res; 1984; 149():257-70. PubMed ID: 6204340
    [No Abstract]   [Full Text] [Related]  

  • 30. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
    Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
    J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA antigens and drug toxicity in rheumatoid arthritis.
    Ford PM
    J Rheumatol; 1984 Jun; 11(3):259-61. PubMed ID: 6610749
    [No Abstract]   [Full Text] [Related]  

  • 32. Age--related heterogeneity of insulin-dependent diabetes mellitus.
    Deschamps I; Lestradet H; Goderel I; Marcelli-Barge A; Schmid M; Hors J
    Diabete Metab; 1983 Dec; 9(4):259-63. PubMed ID: 6607851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphocyte abnormality associated with HLA-B8 in healthy young adults.
    McCombs CC; Michalski JP
    J Exp Med; 1982 Sep; 156(3):936-41. PubMed ID: 6980966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro lymphocyte proliferation response to therapeutic insulin components. Evidence for genetic control by the human major histocompatibility complex.
    Mann DL; Mendell N; Kahn CR; Johnson AH; Rosenthal A
    J Clin Invest; 1983 Sep; 72(3):1130-8. PubMed ID: 6411767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [HLA system and relationship between microorganisms and host; an important factor in vaccination?].
    van Eden W
    Ned Tijdschr Geneeskd; 1986 Apr; 130(17):772-5. PubMed ID: 2423889
    [No Abstract]   [Full Text] [Related]  

  • 36. Human leukocyte antigen-A, -B, -C tissue types in patients with middle ear cholesteatoma.
    Felding JU; Pedersen CB; Lamm LU
    Ann Otol Rhinol Laryngol; 1988; 97(2 Pt 1):192-4. PubMed ID: 3258487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The HLA system and predisposition to diseases].
    Ercilla MG
    Med Clin (Barc); 1989 Dec; 93(20):775-7. PubMed ID: 2695709
    [No Abstract]   [Full Text] [Related]  

  • 38. HLA serology--1983.
    Grumet FC
    Prog Clin Biol Res; 1984; 149():207-20. PubMed ID: 6204338
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immunogenetics of primary membranous glomerulonephritis].
    Berthoux FC; Berthoux P; Hassan AA; Vacherot C; Pomier G; Laurent B; Le Petit JC
    Presse Med; 1990 May; 19(21):990-3. PubMed ID: 2141152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of immune response genes on the expression of disease.
    Stobo JD
    J Lab Clin Med; 1982 Dec; 100(6):822-8. PubMed ID: 6815287
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.